Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02411305 · ClinicalTrials.gov registry record
Feasibility Testing of the Quality-monitoring Tool, Qdact, for the Palliative Care Research Cooperative
A clinical trial, sponsored by Duke University.
- Completed
- Registry status
- 40
- Enrollment target
NCT02411305: Completed study, sponsored by Duke University.
NCT02411305 is a clinical trial that has completed, run by Duke University. The registered enrollment target is 40 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02411305 has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- 40 participants
- Enrollment target
Study Summary
Few formal mechanisms for collecting, analyzing, and reporting data on quality in palliative care exist. Such infrastructure is needed to understand current clinical practices, inform quality improvement projects, and research which links adherence to specific quality measures and improved patient-centered outcomes. This infrastructure, if proven feasible, can then become integrated into usual palliative care delivery across the PCRC. Then, palliative care can conduct the same types of collaborative quality improvement activities, based on data collected at point of care, as other medical disciplines like general surgery and cardiology.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2015-02 |
What the finished NCT02411305 record still lists
NCT02411305 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 40 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT02411305 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02411305 about?
NCT02411305 is a clinical study titled "Feasibility Testing of the Quality-monitoring Tool, Qdact, for the Palliative Care Research Cooperative". Few formal mechanisms for collecting, analyzing, and reporting data on quality in palliative care exist. Such infrastructure is needed to understand current clinical practices, inform quality improvement projects, and research which links adherence to specific quality measures and improved patient-c...
What is the current status of trial NCT02411305?
This trial is currently completed. The enrollment target is 40 participants. The study started on 2015-02.
Who is sponsoring clinical trial NCT02411305?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia